Corbus Pharmaceuticals to Present at the 7th Annual LEERINK Partners Global Healthcare Conference
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present in a fireside chat at the 7th Annual LEERINK Partners Global Healthcare Conference on Thursday, February 15th at 2:30 p.m. EST in New York, NY. Read more >>